Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Stakeholders